Jazz Pharmaceuticals' tremor drug fails to meet main goal in mid-stage study-February 2024-www.financetom.com

Jazz Pharmaceuticals' tremor drug fails to meet main goal in mid-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Jazz Pharmaceuticals' tremor drug fails to meet main goal in mid-stage study

Jun 20, 2024 5:21 AM

June 20 (Reuters) - Jazz Pharmaceuticals ( JAZZ ) said

on Thursday its experimental drug to treat a neurological

condition that causes involuntary and rhythmic shaking failed to

meet the main goal in a mid-stage study.

(Reporting by Mariam Sunny in Bengaluru; Editing by Mrigank

Dhaniwala)

Previous page： CERAWEEK-AI, LNG demand to keep US natgas use at record highs but bottlenecks threaten Next page： Waste Connections Insider Sold Shares Worth $2,554,478, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CERAWEEK-AI, LNG demand to keep US natgas use at record highs but bottlenecks threaten

Mar 12, 2025

* Record natgas demand since nearly 2010 seen extending to 2025, 2026 * Power costs up 35% in past 4 years amid lack of gas pipeline capacity -EQT * US LNG capacity will almost double over the next few years * NextEra sees 55% jump in power demand in next 20 yrs, 17% of that from AI By Georgina McCartney...

Waste Connections Insider Sold Shares Worth $2,554,478, According to a Recent SEC Filing

Mar 12, 2025

04:17 PM EDT, 03/12/2025 (MT Newswires) -- Darrell W Chambliss, Executive Vice President & COO, on March 10, 2025, sold 13,566 shares in Waste Connections ( WCN ) for $2,554,478. Following the Form 4 filing with the SEC, Chambliss has control over a total of 95,000 common shares of the company, with 95,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1318220/000156218025002332/xslF345X05/primarydocument.xml ...

Lifestance Health Group Insider Sold Shares Worth $264,293, According to a Recent SEC Filing

Mar 12, 2025

04:18 PM EDT, 03/12/2025 (MT Newswires) -- Pablo Pantaleoni, Chief Digital Officer, on March 07, 2025, sold 35,505 shares in Lifestance Health Group ( LFST ) for $264,293. Following the Form 4 filing with the SEC, Pantaleoni has control over a total of 1,460,153 common shares of the company, with 937,573 shares held directly and 522,580 controlled indirectly. SEC Filing:...

US chipmaker Intel appoints Lip-Bu Tan as its CEO

Mar 12, 2025

March 12 (Reuters) - Intel ( INTC ) said on Wednesday it has appointed Lip-Bu Tan as chief executive officer effective March 18. (Reporting by Bhanvi Satija in Bengaluru; Editing by Arun Koyyur) ...